Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Equity Average (2016 - 2026)

Usana Health Sciences has reported Equity Average over the past 17 years, most recently at $538.3 million for Q2 2026.

  • Quarterly Equity Average rose 1.39% to $538.3 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $538.3 million through Apr 2026, up 1.39% year-over-year, with the annual reading at $532.6 million for FY2026, 3.49% up from the prior year.
  • Equity Average was $538.3 million for Q2 2026 at Usana Health Sciences, up from $530.6 million in the prior quarter.
  • Over five years, Equity Average peaked at $538.3 million in Q2 2026 and troughed at $392.5 million in Q2 2022.
  • The 5-year median for Equity Average is $491.2 million (2023), against an average of $477.6 million.
  • Year-over-year, Equity Average fell 7.03% in 2022 and then grew 16.45% in 2023.
  • A 5-year view of Equity Average shows it stood at $422.8 million in 2022, then rose by 14.43% to $483.8 million in 2023, then rose by 10.09% to $532.6 million in 2024, then fell by 0.57% to $529.6 million in 2025, then increased by 1.65% to $538.3 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Equity Average are $538.3 million (Q2 2026), $530.6 million (Q1 2026), and $529.6 million (Q3 2025).